Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Tue, 23 Oct 18 19:09:59 +0000 Tue, 23 Oct 18 19:09:59 +0000 Global Operation Targets Illegal Drug Sales on Web To target the infrastructure supporting the illegal online sales of drugs, a series of recent OCI cybercrime investigations focused on credit card processors involved in an arrangement known as &ldquo;transaction laundering&rdquo; or &ldquo;factoring.&rdquo; Tue, 23 Oct 18 15:43:00 +0000 Investigational MS Therapy Showed Positive Results in Phase 2 Study New data from the investigational multiple sclerosis (MS) drug evobrutinib showed that the therapy reduced lesions and decreased annual relapse rates in patients with relapsing MS. Tue, 23 Oct 18 15:00:00 +0000 FDA Meeting Aims to Increase Availability of Naloxone for Reducing Opioid Overdose Deaths The FDA will address new ways to increase the availability of <a href=""><strong>naloxone</strong></a>, during a 2-day advisory committee meeting in December. Tue, 23 Oct 18 14:15:00 +0000 Monday Pharmaceutical Mystery: October 22 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 22 Oct 18 13:00:00 +0000 New Tele-Pharmacy Software Offers Face to Face Interaction Between Pharmacists and Patients This digital technology allows patients to have meaningful conversations with pharmacists from their homes. Thu, 18 Oct 18 20:00:00 +0000 Reflections on National Pharmacy Technician Day 2018 Pharmacy technicians across the country are being honored today in recognition of National Pharmacy Technician Day. Tue, 16 Oct 18 16:00:00 +0000 Treatment for HER2-Negative Breast Cancer with Germline BRCA Mutation Granted FDA Approval Talazoparib, a poly ADP-ribose polymerase (PARP) inhibitor, is indicated for patients with known deleterious or suspected deleterious gBRCA-mutated breast cancer who are selected for the therapy based on an FDA-approved companion diagnostic. Tue, 16 Oct 18 16:00:00 +0000 Monday Pharmaceutical Mystery: October 15 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 15 Oct 18 13:00:00 +0000 Increasing E-Cigarette Sales to Minors Prompts FDA to Crack Down E-cigarettes can be beneficial tool for smoking cessation, but the use of e-cigarettes in minors can be dangerous. Fri, 12 Oct 18 19:40:00 +0000 Female Industry Leaders Weigh in on Pharmacy Ownership for National Women Pharmacists Day In recognition of the first National Women Pharmacists Day today, October 12,&nbsp;<u><a href=""><strong>Specialty Pharmacy Times</strong></a></u>&nbsp;conducted an interview with female pharmacy leaders and a pharmacy student to hear their unique perspectives on the state of the industry, as well as challenges and opportunities in store ownership.&nbsp;&nbsp;&nbsp; Fri, 12 Oct 18 14:15:00 +0000 New Pharmacogenomics Certificate Program Available to Pharmacists A new program available through the American Society of Health-System Pharmacists is 1 of multiple&nbsp;Pharmacogenomics Certificate courses available to pharmacists.&nbsp; Thu, 11 Oct 18 16:00:00 +0000 Viral Video a Hit For Pharmacy Students and Dog Ashlynn Dacus, a student at Harding University College of Pharmacy in Arkansas, was attempting to do a &#39;What the Fluff&#39; challenge with her Saint Bernard, Maggie. Wed, 10 Oct 18 19:00:00 +0000 DOJ Approval Moves Forward Merger of CVS and Aetna The Department of Justice (DOJ) today granted conditional approval to the $69 billion merger between CVS Health Corporation and Aetna Inc, as long as Aetna sells its Medicare Part D prescription drug plan business. Wed, 10 Oct 18 17:00:00 +0000 Monday Pharmaceutical Mystery: October 8 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 08 Oct 18 13:00:00 +0000 FDA Approves Second Drug Treatment for Polyneuropathy The FDA has approved Akcea Therapeutics&#39; inotersen (Tegsedi), an antisense oligonucleotide that inhibits the production of the transthyretin protein (amyloid), for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. Sat, 06 Oct 18 16:00:00 +0000 Study Finds Almost Half of Antibiotic Prescriptions Written Without a Diagnosis Although their use is sometimes necessary, overprescribing the bacteria-killing drugs can be dangerous.&nbsp;<br /> &nbsp; Fri, 05 Oct 18 19:56:00 +0000 PQA Applauds Congressional Passage of Opioid Legislation The Pharmacy Quality Alliance has praised the bipartisan efforts of Congress in passing the SUPPORT for Patients and Communities Act (HR 6). Fri, 05 Oct 18 19:29:00 +0000 FDA Approves Prophylactic Treatment for Individuals With Hemophilia A Officials with the FDA have approved emicizumab-kxwh (Hemlibra, Genentech) for routine prophylaxis to prevent or reduce frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors. Thu, 04 Oct 18 18:00:00 +0000 Sarecycline Granted FDA Approval for Acne Vulgaris The FDA has approved sarecycline (Seysara, Almirall) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 years and older. Wed, 03 Oct 18 16:00:00 +0000 Pharmacy Times Launches Social Media Campaign to #ThankAPharmacist During American Pharmacists Month Wed, 03 Oct 18 13:47:00 +0000 ASHP Provides Guidelines for Preventing Medication Errors in Hospitals The American Society of Health-System Pharmacists (ASHP) has published guidelines with practical recommendations and best practices for preventing patient harm from medication errors. Tue, 02 Oct 18 16:00:00 +0000 DEA's New Cannabidiol Classification Helps Seizure Treatment Become Accessible The Drug Enforcement Administration is placing Epidiolex in Schedule V, the least restrictive of the Controlled Substances Act Mon, 01 Oct 18 20:40:00 +0000 Methocarbamol Tablets for Treating Musculoskeletal Conditions are Recalled Two lots of Robaxin&reg; (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack are being voluntarily recalled by&nbsp;Endo Pharmaceuticals Inc., due to incorrent dosing information on the label. Mon, 01 Oct 18 19:44:00 +0000 Monday Pharmaceutical Mystery: October 1 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 01 Oct 18 13:00:00 +0000 FDA Approves New Epinephrine Product for Children Officials with the FDA have approved Admais&rsquo; 0.15mg Symjepi for the emergency treatment of allergic reactions, including anaphylaxis, in children. Sat, 29 Sep 18 16:19:00 +0000